DEMENTIA FRONTOTEMPORAL
Clinical trials for DEMENTIA FRONTOTEMPORAL explained in plain language.
Never miss a new study
Get alerted when new DEMENTIA FRONTOTEMPORAL trials appear
Sign up with your email to follow new studies for DEMENTIA FRONTOTEMPORAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain-Delivered gene therapy tested to halt rare, Early-Onset dementia
Disease control Recruiting nowThis early-stage study is testing a one-time gene therapy called AVB-101 for people with a specific genetic form of frontotemporal dementia (FTD-GRN). The therapy is delivered directly into the brain during a single procedure, aiming to restore a missing protein and potentially s…
Matched conditions: DEMENTIA FRONTOTEMPORAL
Phase: PHASE1, PHASE2 • Sponsor: AviadoBio Ltd • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Brain injection trial aims to slow devastating dementia
Disease control Recruiting nowThis early-stage study is testing a one-time gene therapy injection for adults with specific genetic forms of frontotemporal dementia (FTD). The treatment, called PBFT02, aims to deliver a working copy of a missing or faulty gene directly to the brain to potentially slow disease …
Matched conditions: DEMENTIA FRONTOTEMPORAL
Phase: PHASE1, PHASE2 • Sponsor: Passage Bio, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Can speaking two languages help protect the brain? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand if speech therapy tailored for bilingual people can help those with primary progressive aphasia, a condition that causes worsening language problems. Researchers will test 60 bilingual participants to see if practicing in both their languages improve…
Matched conditions: DEMENTIA FRONTOTEMPORAL
Phase: NA • Sponsor: University of Texas at Austin • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC